Novartis verzeichnet ein starkes erstes Quartal und ergreift Schritte, um ein stärker fokussiertes Arzneimittelunternehmen zu werden

NEXT STORY
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)
PREV STORY
Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Publishing of Orion Corporation’s Interim Report for January-September 2017 on 26 October 2017

ORION CORPORATION     PRESS RELEASE   12 OCTOBER 2017 at 10.30 A.M. EEST Publishing of Orion ...

author_avatar
NASDAQ Market News

Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference

SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

author_avatar
NASDAQ Market News

TLC Files Registration Statement for Proposed Initial Public Offering

TAIPEI, Taiwan, Feb. 17, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), ...

author_avatar
NASDAQ Market News